ABSTRACT
Background
Wider screening and assessment for Alzheimer's disease and other related dementias (ADRD) may increase access to supportive care, improve allocation of medical care, and foster the use of interventions that prevent or delay disease progression. Yet, the effect of diagnostic timing on clinical and utilization outcomes is poorly understood. Community‐based settings such as a hospital emergency department (ED) may be an underrecognized opportunity to assess cognition and impacts on individuals and health systems. This study assessed the feasibility of recruiting older adults for telephone‐based trials following presentation to the ED and administering telephone based cognitive assessments over the phone in this population.
Methods
Medicare‐enrolled individuals 65+ years of age (n = 160) presenting to the Oregon Health & Science University Emergency Department (Portland, Oregon) between May 2022 and February 2023 were recruited by telephone. Participants were administered the Telephone Interview for Cognitive Status (TICS) Assessment and the Patient Reported Outcomes Measurement Information System (PROMIS) Cognitive Measure Questions on Mental Clarity via telephone 1–12 weeks post‐discharge to evaluate cognition. Electronic medical records (EMR) were reviewed for medical care utilization including primary care provider (PCP) visits, hospital admissions, and ED visits for the 3 years prior to ED presentation.
Results
Twenty‐six percent of eligible ED users contacted elected for study enrollment. The TICS Assessment score had a significant relationship with the three evaluated health care utilization measures (ED, PCP visits, or hospitalizations); the PROMIS Assessment had significant but weak correlations to ED and PCP visits.
Conclusions
Older adults 65+ years presenting to the ED are amenable to enroll in telephone‐based cognition‐focused trials and cognitive assessments can be carried out over the telephone in this population. The PROMIS Assessment may be a better cognition assessment tool when evaluating for cognition and care utilization in this population. In addition to the limits of the screening tools used in this study, a lack of a representative sample is a limitation of the study design. Future studies could use other validated cognitive assessment tools and utilize a study design with a recruitment strategy focused on obtaining a representative sample of older ED patients.
Keywords: Alzheimer's disease, cognitive assessment, emergency department, implementation research
Summary.
Cognitive assessments within community‐based settings such as emergency departments (ED) are an important approach for reaching diverse populations whose access and engagement with the formal health care system may be limited.
Older adults 65+ years of age presenting to the ED are amenable to enroll in telephone‐based cognition‐focused trials and cognitive assessments can be carried out over the telephone.
The TICS Assessment score was significantly correlated with the three evaluated health care utilization measures in this study (ED, primary care physician [PCP] visits, and hospitalizations); the PROMIS assessment of cognition was correlated with ED and PCP visits.
Results provide preliminary evidence to support a focus on cognitive screening of older ED patients.
1. Introduction
The global number of older adults with Alzheimer's disease and related dementias (ADRD) is projected to increase to approximately 152 million by 2050 [1]. Several organizations including the World Health Organization (WHO) have identified a timely and accurate diagnosis of ADRD as a top public health priority [2]; however, an estimated 59% of persons in the United States (US)with ADRD never receive a formal diagnosis [3]. The rates of ADRD underdiagnosis are higher for other regions of the world including Brazil at 77% and China with as much as 80% [4, 5]. Widespread underdiagnosis compromises the wellbeing of persons with ADRD and their care partners (CP) and increases health services utilization and costs of care including those borne by US public programs like Medicare and Medicaid. In 2024 alone, ADRD care cost Medicare and Medicaid over $231 billion [6].
Wider and earlier screening and assessment for ADRD may increase access to supportive care, improve allocation of medical care resources, and foster the use of interventions that prevent or delay disease progression [7]. Barnett et al. (2014) projected implementing interventions 3–9 years earlier than the current average initiation of treatment would reduce care costs on average 17% per year [8]. An additional potential benefit is that as new disease modifying treatments become available, earlier screening may produce even greater savings to health systems and to programs that fund ADRD care, as well as increase the potential benefits of earlier treatment initiation for those with the disease [9, 10]. Zissimopoulos, Crimmins, and Clair (2014) showed delaying dementia onset by 5 years may increase life expectancy by 2.7 years and produces an average cost savings of $511,208 per person [11]. Given the rate of inflation since 2014, the projected savings would be $673,855 per person in June 2024 [12]. The clinical gains for people with ADRD alone would justify earlier and more frequent cognition screening and assessments. Early identification of decline allows for better care planning and disease management regardless of the impacts on costs. Further research is needed to better understand the effects of diagnostic timing.
Most persons with ADRD are diagnosed by a primary care provider (PCP); yet 40%–76% of all people with ADRD go undiagnosed in primary care settings [13, 14, 15]. PCPs face several barriers to making a diagnosis including insufficient training in ADRD assessment and management, a shortage of use of cognitive screening tools, insufficient time in clinical visits, and the perception that nothing can be done to treat or cure the disease. The Medicare Annual Wellness Visit (AWV) is an opportunity to assess cognitive status amongst Medicare beneficiaries in a primary care setting, as this visit requires providers to perform a cognitive assessment. However, Medicare's AWV is more widely utilized by higher income, white, urban beneficiaries, while Medicare‐Medicaid dual‐eligible individuals have a lower rate of utilization than non‐dual Medicare and Medicaid eligible beneficiaries [16]. Furthermore, a 2018 review found that the AWV's requirement of a cognitive status assessment fails to significantly increase the recognition of undetected ADRD amongst Medicare beneficiaries [17]. Thus, alternatives to relying primarily on primary care offices to test cognition that have wider application are warranted.
As an alternative to clinic‐based assessments, cognitive assessment in a community‐based setting accessible to persons of all income levels, races, and ethnicities, such as an emergency department (ED), may provide for earlier and wider cognitive screening. The ED admittedly can be a challenging environment to perform research, including an accurate assessment of cognition, due to the physical, emotional, and cognitive state of many individuals seeking care, space limitations, and the often‐chaotic nature of the ED. ED visits and admission to acute care hospitals have been shown to be an effective setting to obtain an assessment of cognitive status in a simple, relatively un‐intrusive manner [18, 19, 20]. A recent US study successfully implemented a brief and sensitive in‐person cognitive screen in a large urban hospital ED, which resulted in 41.5% of screened adults 75+ years of age showing suspected cognitive impairment [21].
Up to 22% of Medicare enrollees have an ED visit each year [22]. This may be due to complex disease states that are more common in older adults, but also due to the increased utilization of these facilities by those of low socioeconomic status (SES) and non‐white populations, for which healthcare plans that cover regular health maintenance may be cost prohibitive [23, 24, 25]. Further, the only formal interaction many individuals have with the medical system is at a time of crisis. Thus, an ED may offer better access to these populations and an opportunity for interventions including referral for full neurological and neuropsychological assessment. Community‐based settings, such as an ED, may be an underrecognized opportunity to assess cognition and impacts on individuals and health systems including the costs of care. The costs of ED‐based care for Medicare enrolled older adults are high [26, 27]. Augmenting the usual standard of care for older adults through the use of cognitive assessments may be cost‐effective approach [28].
While remote cognitive assessments were used for years prior to the COVID‐19 pandemic [29], the pandemic propelled their widespread use [30, 31]. Multiple options for remote assessment exist including the Telephone Interview for Cognitive Status (TICS), a validated tool for telephone‐based assessments of cognition [32, 33]. Telephone‐based cognitive assessments have been shown to be a suitable method for assessment of cognition [34]. The Patient Reported Outcomes Measurement Information System (PROMIS) Cognitive Measure Questions on Mental Clarity is also a validated tool [35]. Few, if any, studies have explored the use of the TICS or PROMIS among older adults utilizing the ED for care.
This pilot study aimed to (1) investigate the feasibility of using a telephone call after an ED visit to recruit participants into research trials, assessment of acceptability, and completion rates of all study components; (2) assess cognitive status; and (3) measure health care utilization among Medicare‐enrolled older adults. To achieve these aims, this study approached Medicare‐enrolled individuals 65+ years of age consecutively discharged from a large urban emergency department (ED) in Portland, OR. The study used the Telephone Interview for Cognitive Status (TICS) Assessment, and the Patient Reported Outcomes Measurement Information System (PROMIS) Cognitive Measure Questions on Mental Clarity. Participant electronic medical records (EMR) were reviewed to measure health care utilization including primary care provider (PCP) visits, hospital admissions, and ED visits for the 3 years prior to ED presentation.
2. Methods
This study was conducted in accordance with the Declaration of Helsinki and approved by the Oregon Health & Science University (OHSU) Institutional Review Board (IRB) (IRB # 23042: date of approval: 9/8/2021). Target enrollment was 160 people over 12 months. All Medicare‐enrolled individuals 65+ years of age consecutively discharged from the OHSU ED (Portland, Oregon) between May 2022 and February 2023 were assessed for study eligibility. Inclusion criteria were recent discharge from the OHSU ED, a minimum of 65 years of age, Medicare enrolled, and receiving primary care services through the OHSU health system or affiliated sites to allow for electronic medical record (EMR) review for study outcomes. Our sampling strategy was based on general population screening of adults 65 years of age or older due to a higher risk of cognitive impairment and dementia among older adults [36, 37]. Eligible participants were contacted by telephone within 12 weeks following discharge from the ED. After providing informed consent over the telephone, participants were administered the TICS Assessment [32, 33]. Demographics, comorbidity burden using the Modified Cumulative Illness Rating Scale (M‐CIRS), and perceptions of personal cognitive health via the PROMIS Cognitive Measure Questions on Mental Clarity were also collected over the telephone by the study coordinator [38, 39, 40]. Care utilization including PCP visits, hospital admissions, and ED visits for the 3 years prior to presenting to the ED (triggering event) was collected via the EMR by a clinician with expertise in EMR review. All available records in the OHSU EMR, including services at OHSU and services delivered outside of OHSU but included in the OHSU EMR through the Care Everywhere feature, were assessed for the three utilization categories. Due to the concurrent COVID‐19 pandemic, PCP visits in person and via telehealth were counted as a PCP visit. Brief phone calls, EMR messages, and medication refill requests were excluded. Hospital admissions were identified as any time the participant had an overnight stay or was admitted to a hospital for a procedure, such as an outpatient surgery. ED visits were identified as any visit to an ED or urgent care setting for immediate treatment. All records identified to fit into the utilization categories were evaluated for any diagnostic code for cognitive impairment or dementia. These ICD‐10 categories include G31, G30, R41 and F02 codes. The records were reviewed to identify the first utilization of any cognitive impairment diagnosis to determine where the participant received their first diagnosis.
2.1. Statistical Analysis
Participant characteristics were summarized among those with and without a diagnosis of cognitive impairment. Multivariate logistic regression models were used to examine the relationship between cognitive assessments, TICS and PROMIS scores, and diagnosis of cognitive impairment controlling for age, sex, education, and total number of healthcare visits. Spearman's non‐parametric correlations were used to evaluate the relationship between cognitive assessments, (TICS and PROMIS), comorbidity (M‐CIRS) and four measures of healthcare utilization in the last 3 years (total visits, PCP visits, ED visits, hospital admissions). Analyses were performed using R software (version 4.4.1).
3. Results
Between May 2022 and February 2023, EMRs of 2380 Medicare‐enrolled adults 65+ years old who presented to the OHSU ED were reviewed (Table 1). Of those, 607 (26%) were determined to be eligible, of which 160 (26%) were ultimately enrolled. Target enrollment was reached. Of those who declined participation, 247 declined due to lack of interest (40.7%), 94 declined due to cognitive and health concerns (15.5%), 26 were lost to contact (4.3%), and 82 were deceased before telephone contact (13.5%).
TABLE 1.
Enrollment outcomes for medicare‐enrolled older adults presenting to the OHSU ED.
| Recruitment Status | Count | % |
|---|---|---|
| Older adults presenting to ED | 2380 | 100 |
| Ineligible | 1773 | 74 |
| Eligible a | 607 | 26 |
| Enrolled | 160 | 26.4 |
| Declined | 449 | 73.6 |
| Not interested in study | 247 | 40.7 |
| Cognition/health concerns | 94 | 15.5 |
| Unable to reach/lost to follow‐up | 26 | 4.3 |
| Deceased before contact | 82 | 13.5 |
1% (82 people) were deceased prior to contact that otherwise would have been eligible.
During the enrollment period, the enrollment rate was 4.1 enrollments per week, although in four of these weeks the study team did not actively recruit (4.5 enrollment rate/35 weeks). The mean time between the triggering ED visit and study enrollment was 33 days (min = 21, max = 115). The average time to first contact was 33 ± 23 days (min = 0, max = 148) The time to administer the consenting and study assessments over the phone ranged between 26 and 33 min. Out of the 160 who enrolled, 159 participants completed all components of the study including the TICS and PROMIS.
Of the 160 older adults enrolled, 55% were female and 96% were non‐Hispanic white, mean age 74.6 ± 6.6 years (Table 2). Twenty‐five (16%) had a diagnosis of cognitive impairment (CI) per EMR abstraction. Those with CI were significantly older than those with no CI (79.1 vs. 73.8 years). Those with CI did not have significantly different TICS scores than those with no CI (33.4 vs. 34.1). However, those with CI did have significantly lower PROMIS scores (13.1 vs. 15.1) compared to those with no CI. Participants with a diagnosis of CI had higher numbers of healthcare visits overall in the past 3 years, however this did not reach statistical significance (21.8 vs. 16.4).
TABLE 2.
Participant characteristic with and without cognitive impairment.
| No cognitive impairment diagnosis | Cognitive impairment diagnosis | p‐value | |
|---|---|---|---|
| N | 135 | 25 | |
| Mean (SD) or N (%) | Mean (SD) or N (%) | ||
| Female | 74 (55%) | 13 (52%) | 0.70 |
| Non‐Hispanic white | 130 (96.3%) | 25 (100%) | 0.97 |
| Mean (SD) | Mean (SD) | ||
|---|---|---|---|
| Age at ED visit | 73.8 (6.4) | 79.1 (6.1) | < 0.001** |
| Education, yrs | 16.3 (2.6) | 16.1 (2.7) | 0.70 |
| M‐CIRS | 24.3 (4.5) | 25.1 (4.9) | 0.40 |
| TICS score | 34.1 (3.2) | 33.4 (3.6) | 0.40 |
| PROMIS score | 15.1 (3.8) | 13.1 (3.6) | 0.01* |
| Number of healthcare visits in the last 3 years | |||
| Total | 16.4 (13.0) | 21.8 (14.0) | 0.05 |
| PCP | 10.6 (8.8) | 14.0 (9.3) | 0.05 |
| Hospital | 2.5 (2.9) | 3.0 (2.5) | 0.20 |
| ED | 3.3* (4.0) | 4.8 (5.0) | 0.12 |
Abbreviations: ED = Emergency Department; M‐CIRS = Modified Cumulative Illness Rating Scale; PCP = Primary Care Provider; PROMIS = Patient Reported Outcomes Measurement Information System; TICS = Telephone Interview for Cognitive Status.
p‐value < 0.05.
p‐value < 0.01.
We ran logistic regression models to examine the relationship between the two baseline cognitive assessments, TICS and PROMIS scores, and diagnosis of CI controlling for age, education, sex, and total healthcare visits in last 3 years (Table 3). Again, TICS score was not significantly associated with CI (p = 0.79). Additionally, older age and more healthcare visits were associated with CI (p < 0.001 and p = 0.03 respectively). However, lower PROMIS scores were significantly associated with CI (p = 0.02).
TABLE 3.
Multivariate models of cognitive assessments and prior diagnosis of cognitive impairment.
| Variables | Odds ratio | 95% CI | p‐value |
|---|---|---|---|
| TICS total score | 1.02 | 0.88–1.19 | 0.79 |
| Age, yrs | 1.13 | 1.05–1.21 | < 0.001** |
| Education, yrs | 0.94 | 0.78–1.12 | 0.48 |
| Female sex | 0.72 | 0.26–1.99 | 0.52 |
| Health care visits in last 3 years | 1.05 | 1.01–1.09 | 0.03* |
| Variables | Odds ratio | 95% CI | p‐value |
|---|---|---|---|
| PROMIS total score | 0.86 | 0.76–0.98 | 0.02* |
| Age, yrs | 1.15 | 1.06–1.23 | < 0.001** |
| Education, yrs | 0.96 | 0.80–1.15 | 0.63 |
| Female sex | 0.68 | 0.24–1.93 | 0.47 |
| Health care visits in last 3 years | 1.03 | 0.99–1.08 | 0.11 |
Abbreviations: PROMIS = Patient Reported Outcomes Measurement Information System; TICS = Telephone Interview for Cognitive Status.
p‐value < 0.05.
p‐value < 0.01.
Higher TICS total score was significantly correlated with fewer total healthcare visits, ED visits, and hospitalizations. Higher PROMIS total score was significantly correlated with fewer total number of healthcare visits, ED, and PCP visits. Higher M‐CIRS, a measure of comorbidity, was positively correlated with all measures of healthcare utilization (Table 4).
TABLE 4.
Spearman correlation coefficients between cognition, comorbidity and healthcare utilization counts in past 3 years.
| Assessment | Total healthcare visits | ED visits | Hospital visits | PCP visits |
|---|---|---|---|---|
| TICS score | −0.17* | −0.18* | −0.16* | −0.12 |
| PROMIS score | −0.23** | −0.19* | −0.14 | −0.22** |
| M‐CIRS score | 0.45*** | 0.34*** | 0.46*** | 0.31*** |
Abbreviations: ED = Emergency Department; M‐CIRS = Modified Cumulative Illness Rating Scale; PCP = Primary Care Provider; PROMIS = Patient Reported Outcomes Measurement Information System; TICS = Telephone Interview for Cognitive Status.
p ≤ 0.05.
p < 0.01.
p < 0.0001.
4. Discussion
The goals of this study were to assess the feasibility of enrolling older adults in a research trial following an ED visit, conduct cognitive assessments in this population over the telephone, utilize electronic medical records (EMR) to assess health care utilization within this population, and assess for relationships between cognition diagnosis, telephone cognitive measures, and health care utilization. We found that approximately 25% of eligible Medicare‐enrolled adults 65+ years of age recently discharged from an ED were amenable to participation in research and cognitive assessment by telephone. We also found that the prevalence of cognitive impairment (16%) in our sample was aligned with prevalence rates among the general population of older adults in their mid‐seventies. We encountered barriers to enrollment due to the language of the consent forms provided to prospective participants. Some potential participants noted the consent forms made them wary of participation, including a few participants who ultimately did enroll in this study after discussion with the study coordinator. With the complex nature of cognitive impairment, we were unable to recruit persons with more advanced stages of cognitive decline. This is likely due to enrollment bias among healthier participants due to the need for sufficient time and attention to complete the consenting process in addition to telephone‐based questionnaires.
Due to the demographics of the Portland, Oregon metropolitan area, we were unable to recruit a diverse sample necessitating future studies in locations with a more diverse demographic. This study was also unable to recruit many individuals living in rural areas or of lower socioeconomic status (SES). There are several possible reasons for this including the study design focusing on individuals who received their primary care through the OHSU health system, which limited the participant pool. This was necessary to be able to utilize an EMR for health care utilization assessments. Pivoting from an in‐person to a telephone‐based approach due to COVID‐19 pandemic related restrictions in this population may have limited our engagement with diverse communities, socioeconomically disadvantaged individuals, and several difficult to reach populations including the unhoused who are less likely to be reachable post discharge from a healthcare setting [41, 42]. Participants who ultimately enrolled were more likely to have higher levels of educational attainment, be white non‐Hispanic, and be in better overall physical (as measured by the M‐CIRS) and cognitive health. Very few individuals dually eligible for Medicare and Medicaid enrolled suggesting a higher SES sample. To obtain a more representative sample, several approaches could be taken when designing future research on administering cognitive assessments with the ED population 65+. Future studies might focus recruitment efforts on diverse populations, add a recruitment site based within a rural community, translate study‐related documents (e.g., consent forms, recruitment materials) into multiple languages, partner with community‐based organizations who routinely work with specific populations to recruit participants, involve community stakeholders in the study design including the development of recruitment materials in partnership with a community advisory board, and recruit bilingual and bicultural study team members to lead outreach recruitment efforts among populations whose primary language is not English [43, 44, 45].
Future studies focused on recently ED discharged older adults may consider using the modified TICS Assessment (M‐TICS), which has been validated for use to detect dementia, or the Montreal Cognitive Assessment (MoCA), which may be more effective at isolating mild cognitive impairment (MCI) when delivered remotely [46, 47, 48]. When administered remotely, the MoCA has been shown to be as effective in cognitive assessment as when administered face‐to‐face [49, 50]. The PROMIS Questions of Mental Clarity, however, was a more effective screening measure in this study, and as a brief, patient‐reported cognitive assessment, it may offer advantages over the TICS, which takes longer to administer. The flexibility afforded by how and when the PROMIS Questions of Mental Clarity are administered may also offer a way to easily attain data on cognition within community‐based settings which may be particularly well‐suited for use with older adults post‐discharge from the ED [51, 52, 53]. Further, the standardization and general ease of interpretation of PROMIS scores may facilitate simple documentation within patient medical records, allowing for the monitoring of longitudinal changes in cognition [54, 55].
We found that older age and more total healthcare visits were associated with cognitive impairment. This is expected as advanced age is a well‐established risk factor for cognitive impairment [56]. We also found a higher TICS total score to be significantly correlated with fewer total healthcare visits, ED visits, and hospitalizations. Individuals with a diagnosis of dementia also have higher rates of healthcare utilization as compared to those without [57, 58]. This is important for evaluating the role of the ED in the continuum of care for older adults. Moreover, it is important for reevaluating the usual standard of care of older adults in the ED, particularly given a high rate of underdiagnosed dementia among the general population [3]. We also found a higher M‐CIRS score was positively correlated with all measures of healthcare utilization. This is also expected as comorbidity and multimorbidity often results in increased utilization of health care among older adults [59].
Future research might include long‐term follow‐up of participants to assess the ongoing benefits of cognitive assessments as this may offer a way to provide effective care planning, interventions to support of care partners, and monitor disease progression [60, 61]. Future work may also include measuring the cost‐effectiveness of assessments with visitors 65+ years to the ED adding evidence for whether earlier detection of ADRD produces a cost savings to health systems and the public programs that fund care. This would facilitate the determination if a meaningful difference in healthcare costs exists between older adults with a diagnosis of ADRD versus those who do not but have suspected cognitive impairment based on their TICS score. Additional analyses are also needed to confirm whether older adults in the ED population are appropriate for broadly implemented cognitive screening and assessment. Taking an in‐person approach to cognitive screening and assessment within the ED may be warranted in future follow‐up studies; however, additional assessment of remote options is also warranted given widespread adoption of and preference for telehealth after the COVID‐19 pandemic and to improve access to more rural and diverse populations [62, 63, 64]. These remote approaches are not without limitations including reimbursement concerns related to Medicare or limitations with their efficacy when used with individuals with severe ADRD [65, 66]. More broadly, the use of telehealth‐based cognitive assessments may be limited with older adults due to a lack of desire to use telehealth, a high prevalence of hearing impairment among this population, and a perceived lack of support to navigate the process [67, 68]. These barriers to the wider use of telehealth among older adults are exacerbated by socioeconomic disparities and language barriers.
5. Conclusions
We found that it is feasible to recruit cognitively intact or mildly impaired older adults discharged from the ED into remote research and that it is possible to administer cognitive assessments over the phone with this population. This study provides preliminary evidence supporting a focus on older ED patients to administer cognitive assessments, with the aim of linking outcomes to the EMR and ultimately providing a platform for future research on the impact of under‐diagnosed ADRD on health outcomes and healthcare utilization. This study provides vital background data regarding further development of this model for assessing at a population level the impact and outcomes of under‐diagnosed ADRD. These findings can also help inform clinicians, as well as policymakers, about the impact of earlier detection efforts on reducing the burden of ADRD through disease symptom management and advanced care planning. This approach within a community‐based setting like an ED is especially important for reaching diverse populations of low SES, ethnic and racial minority populations, and military veterans whose access and engagement with the formal health care system may be particularly limited. Future research should consider ongoing follow up and a study design with a focus on recruitment efforts with diverse populations to achieve a more representative sample of the older adult population utilizing the ED.
Conflicts of Interest
The authors declare no conflicts of interest.
Acknowledgments
The authors are grateful for the research participants who volunteered their time to be in this study. We acknowledge the contributions of James G. Kahn to the initial development and design of this study and the support of the Global Brain Health Institute.
Funding: This study was supported by a Global Brain Health Institute/Alzheimer's Association Pilot Award for Global Brain Health Leaders (GBHI ALZ UK‐20‐640170). Additional support was provided by the Layton Aging & Alzheimer's Disease Research Center at Oregon Health & Science University, P30AG024978 and P30AG066518.
Data Availability Statement
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
References
- 1. Nichols E., Steinmetz J. D., Vollset S. E., et al., “Estimation of the Global Prevalence of Dementia in 2019 and Forecasted Prevalence in 2050: An Analysis for the Global Burden of Disease Study 2019,” Lancet Public Health 7, no. 2 (2022): e105–e125, 10.1016/s2468-2667(21)00249-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. World Health Organization . Dementia: A Public Health Priority (World Health Organization, 2012). [Google Scholar]
- 3. Amjad H., Roth D. L., Sheehan O. C., Lyketsos C. G., Wolff J. L., and Samus Q. M., “Underdiagnosis of Dementia: An Observational Study of Patterns in Diagnosis and Awareness in US Older Adults,” Journal of General Internal Medicine 33, no. 7 (2018): 1131–1138, 10.1007/s11606-018-4377-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Nakamura A. E., Opaleye D., Tani G., and Ferri C. P., “Dementia Underdiagnosis in Brazil,” Lancet 385, no. 9966 (2015): 418–419, 10.1016/s0140-6736(15)60153-2. [DOI] [PubMed] [Google Scholar]
- 5. Lang L., Clifford A., Wei L., et al., “Prevalence and Determinants of Undetected Dementia in the Community: A Systematic Literature Review and a Meta‐Analysis,” BMJ Open 7, no. 2 (2017): e011146, 10.1136/bmjopen-2016-011146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. 2024 Alzheimer's Disease Facts and Figures,” Alzheimers Dement 20, no. 5 (2024): 3708–3821, 10.1002/alz.13809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Brayne C., Fox C., and Boustani M., “Dementia Screening in Primary Care: Is it Time?,” JAMA 298, no. 20 (2007): 2409–2411, 10.1001/jama.298.20.2409. [DOI] [PubMed] [Google Scholar]
- 8. Barnett J. H., Lewis L., Blackwell A. D., and Taylor M., “Early Intervention in Alzheimer's Disease: A Health Economic Study of the Effects of Diagnostic Timing,” BMC Neurology 14, no. 1 (2014): 101, 10.1186/1471-2377-14-101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Mintun M. A., Lo A. C., Duggan Evans C., et al., “Donanemab in Early Alzheimer's Disease,” New England Journal of Medicine 384, no. 18 (2021): 1691–1704, 10.1056/nejmoa2100708. [DOI] [PubMed] [Google Scholar]
- 10. van Dyck C. H., Swanson C. J., Aisen P., et al., “Lecanemab in Early Alzheimer's Disease,” New England Journal of Medicine 388, no. 1 (2023): 9–21, 10.1056/nejmoa2212948. [DOI] [PubMed] [Google Scholar]
- 11. Zissimopoulos J., Crimmins E., and St Clair P., “The Value of Delaying Alzheimer's Disease Onset,” Forum for Health Economics & Policy 18, no. 1 (2014): 25–39, 10.1515/fhep-2014-0013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Statistics, B.o.L . CPI Inflation Calculator, 2024), https://data.bls.gov/cgi‐bin/cpicalc.pl.
- 13. Valcour V. G., Masaki K. H., Curb J. D., and Blanchette P. L., “The Detection of Dementia in the Primary Care Setting,” Archives of Internal Medicine 160, no. 19 (2000): 2964–2968, 10.1001/archinte.160.19.2964. [DOI] [PubMed] [Google Scholar]
- 14. Boise L., Morgan D. L., Kaye J., and Camicioli R., “Delays in the Diagnosis of Dementia: Perspectives of Family Caregivers,” American Journal of Alzheimer's Disease 14, no. 1 (1999): 20–26, 10.1177/153331759901400101. [DOI] [Google Scholar]
- 15. Patnode C. D., Perdue L. A., Rossom R. C., et al., “Screening for Cognitive Impairment in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force,” JAMA 323, no. 8 (2020): 764–785, 10.1001/jama.2019.22258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Ganguli I., Souza J., McWilliams J. M., and Mehrotra A., “Trends in Use of the US Medicare Annual Wellness Visit, 2011‐2014,” JAMA 317, no. 21 (2017): 2233–2235, 10.1001/jama.2017.4342. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Fowler N. R., Campbell N. L., Pohl G. M., et al., “One‐Year Effect of the Medicare Annual Wellness Visit on Detection of Cognitive Impairment: A Cohort Study,” Journal of the American Geriatrics Society 66, no. 5 (2018): 969–975, 10.1111/jgs.15330. [DOI] [PubMed] [Google Scholar]
- 18. Nowroozpoor A., Dussetschleger J., Perry W., et al., “Detecting Cognitive Impairment and Dementia in the Emergency Department: A Scoping Review,” Journal of the American Medical Directors Association 23, no. 8 (2022): 1314.e31–1314.e88, 10.1016/j.jamda.2022.03.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Pendlebury S. T., Klaus S. P., Mather M., de Brito M., and Wharton R. M., “Routine Cognitive Screening in Older Patients Admitted to Acute Medicine: Abbreviated Mental Test Score (AMTS) and Subjective Memory Complaint versus Montreal Cognitive Assessment and IQCODE,” Age and Ageing 44, no. 6 (2015): 1000–1005, 10.1093/ageing/afv134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Eagles D., Otal D., Wilding L., et al., “Evaluation of the Ottawa 3DY as a Screening Tool for Cognitive Impairment in Older Emergency Department Patients,” American Journal of Emergency Medicine 38, no. 12 (2020): 2545–2551, 10.1016/j.ajem.2019.12.036. [DOI] [PubMed] [Google Scholar]
- 21. Sunkara N., Sanchez M., Hernandez A., et al., “Cognitive Impairment Screening for Older Emergency Department Patients Using Volunteers,” Journal of the American Geriatrics Society 67, no. S1 (2019): S9–S10. [Google Scholar]
- 22. Venkatesh A. K., Mei H., Kocher K. E., et al., “Identification of Emergency Department Visits in Medicare Administrative Claims: Approaches and Implications,” Academic Emergency Medicine 24, no. 4 (2017): 422–431, 10.1111/acem.13140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Tang N., Stein J., Hsia R. Y., Maselli J. H., and Gonzales R., “Trends and Characteristics of US Emergency Department Visits, 1997–2007,” JAMA 304, no. 6 (2010): 664–670, 10.1001/jama.2010.1112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Kangovi S., Barg F. K., Carter T., Long J. A., Shannon R., and Grande D., “Understanding Why Patients of Low Socioeconomic Status Prefer Hospitals Over Ambulatory Care,” Health Affairs 32, no. 7 (2013): 1196–1203, 10.1377/hlthaff.2012.0825. [DOI] [PubMed] [Google Scholar]
- 25. Mc Namara R., Trepel D., Ferrgusson R., and Glaser K., “50Determinants in Older Adults Who Frequently Attend the Emergency Department,” Age and Ageing 47, no. suppl_5 (2018): v13–v60, 10.1093/ageing/afy140.38. [DOI] [Google Scholar]
- 26. Reider L., Falvey J. R., Okoye S. M., Wolff J. L., and Levy J. F., “Cost of U.S Emergency Department and Inpatient Visits for Fall Injuries in Older Adults,” Injury 55, no. 2 (2024): 111199, 10.1016/j.injury.2023.111199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Gettel C. J., Salah W., Rothenberg C., et al., “Total and Out‐Of‐Pocket Costs Surrounding Emergency Department Care Among Older Adults Enrolled in Traditional Medicare and Medicare Advantage,” Annals of Emergency Medicine 84, no. 3 (2024): 285–294, 10.1016/j.annemergmed.2024.04.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Trépel D., Ruiz‐Adame M., Cassarino M., et al., “The Cost Effectiveness of Early Assessment and Intervention by a Dedicated Health and Social Care Professional Team for Older Adults in the Emergency Department Compared to Treatment‐As‐Usual: Economic Evaluation of the OPTI‐MEND Trial,” PLoS One 19, no. 6 (2024): e0298162, 10.1371/journal.pone.0298162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Brearly T. W., Shura R. D., Martindale S. L., et al., “Neuropsychological Test Administration by Videoconference: A Systematic Review and Meta‐Analysis,” Neuropsychology Review 27, no. 2 (2017): 174–186, 10.1007/s11065-017-9349-1. [DOI] [PubMed] [Google Scholar]
- 30. Webb S. S., Kontou E., and Demeyere N., “The COVID‐19 Pandemic Altered the Modality, But Not the Frequency, of Formal Cognitive Assessment,” Disability & Rehabilitation 44, no. 21 (2022): 6365–6373, 10.1080/09638288.2021.1963855. [DOI] [PubMed] [Google Scholar]
- 31. Binng D., Splonskowski M., and Jacova C., “Distance Assessment for Detecting Cognitive Impairment in Older Adults: A Systematic Review of Psychometric Evidence,” Dementia and Geriatric Cognit¡ve Disorders 49, no. 5 (2020): 456–470, 10.1159/000511945. [DOI] [PubMed] [Google Scholar]
- 32. Crooks V. C., Clark L., Petitti D. B., Chui H., and Chiu V., “Validation of Multi‐Stage Telephone‐Based Identification of Cognitive Impairment and Dementia,” BMC Neurology 5, no. 1 (2005): 8, 10.1186/1471-2377-5-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Seo E. H., Lee D. Y., Kim S. G., et al., “Validity of the Telephone Interview for Cognitive Status (TICS) and Modified TICS (TICSm) for Mild Cognitive Imparment (MCI) and Dementia Screening,” Archives of Gerontology and Geriatrics 52, no. 1 (2011): e26–e30, 10.1016/j.archger.2010.04.008. [DOI] [PubMed] [Google Scholar]
- 34. Elliott E., et al., “Accuracy of Telephone‐Based Cognitive Screening Tests: Systematic Review and Meta‐Analysis,” Current Alzheimer Research 17, no. 5 (2020): 460–471, 10.2174/1567205017999200626201121. [DOI] [PubMed] [Google Scholar]
- 35. Cella D., Riley W., Stone A., et al., “The Patient‐Reported Outcomes Measurement Information System (PROMIS) Developed and Tested its First Wave of Adult Self‐Reported Health Outcome Item Banks: 2005‐2008,” Journal of Clinical Epidemiology 63, no. 11 (2010): 1179–1194, 10.1016/j.jclinepi.2010.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Fishman E., “Risk of Developing Dementia at Older Ages in the United States,” Demography 54, no. 5 (2017): 1897–1919, 10.1007/s13524-017-0598-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Hale J. M., Schneider D. C., Mehta N. K., and Myrskylä M., “Cognitive Impairment in the U.S.: Lifetime Risk, Age at Onset, and Years Impaired,” SSM‐Population Health 11 (2020): 100577, 10.1016/j.ssmph.2020.100577. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Parmelee P. A., Thuras P. D., Katz I. R., and Lawton M. P., “Validation of the Cumulative Illness Rating Scale in a Geriatric Residential Population,” Journal of the American Geriatrics Society 43, no. 2 (1995): 130–137, 10.1111/j.1532-5415.1995.tb06377.x. [DOI] [PubMed] [Google Scholar]
- 39. Salvi F., Miller M. D., Grilli A., et al., “A Manual of Guidelines to Score the Modified Cumulative Illness Rating Scale and Its Validation in Acute Hospitalized Elderly Patients,” Journal of the American Geriatrics Society 56, no. 10 (2008): 1926–1931, 10.1111/j.1532-5415.2008.01935.x. [DOI] [PubMed] [Google Scholar]
- 40. Cella D., Yount S., Rothrock N., et al., “The Patient‐Reported Outcomes Measurement Information System (PROMIS): Progress of an NIH Roadmap Cooperative Group During Its First Two Years,” Medical Care 45, no. 5 (2007): S3–s11, 10.1097/01.mlr.0000258615.42478.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Jenkinson J., Wheeler A., Wong C., and Pires L., “Hospital Discharge Planning for People Experiencing Homelessness Leaving Acute Care: A Neglected Issue,” Healthcare Policy 16, no. 1 (2020): 14–21, 10.12927/hcpol.2020.26294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Ramirez A. V., Ojeaga M., Espinoza V., Hensler B., and Honrubia V., “Telemedicine in Minority and Socioeconomically Disadvantaged Communities Amidst COVID‐19 Pandemic,” Otolaryngology ‐ Head and Neck Surgery 164, no. 1 (2021): 91–92, 10.1177/0194599820947667. [DOI] [PubMed] [Google Scholar]
- 43. Heffernan M. E., Barrera L., Guzman Z. R., et al., “Barriers and Facilitators to Recruitment of Underrepresented Research Participants: Perspectives of Clinical Research Coordinators,” Journal of Clinical and Translational Science 7, no. 1 (2023): e193, 10.1017/cts.2023.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Khan N., Keck L., Sykes C., et al., “Diversity, Community Engagement and Co‐Design in Research: A Rapid Review,” BMJ Lead (2024): 001046, 10.1136/leader-2024-001046. [DOI] [PubMed] [Google Scholar]
- 45. García A. A., Zuñiga J. A., and Lagon C., “A Personal Touch: The Most Important Strategy for Recruiting Latino Research Participants,” Journal of Transcultural Nursing 28, no. 4 (2017): 342–347, 10.1177/1043659616644958. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Knopman D. S., Roberts R. O., Geda Y. E., et al., “Validation of the Telephone Interview for Cognitive Status‐Modified in Subjects With Normal Cognition, Mild Cognitive Impairment, or Dementia,” Neuroepidemiology 34, no. 1 (2010): 34–42, 10.1159/000255464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. de Jager C. A., Budge M. M., and Clarke R., “Utility of TICS‐M for the Assessment of Cognitive Function in Older Adults,” International Journal of Geriatric Psychiatry 18, no. 4 (2003): 318–324, 10.1002/gps.830. [DOI] [PubMed] [Google Scholar]
- 48. Tsoi K. K., Chan J. Y. C., Hirai H. W., Wong S. Y. S., and Kwok T. C. Y., “Cognitive Tests to Detect Dementia: A Systematic Review and Meta‐Analysis,” JAMA Internal Medicine 175, no. 9 (2015): 1450–1458, 10.1001/jamainternmed.2015.2152. [DOI] [PubMed] [Google Scholar]
- 49. Loring D. W., Lah J. J., and Goldstein F. C., “Telehealth Equivalence of the Montreal cognitive Assessment (MoCA): Results From the Emory Healthy Brain Study (EHBS),” Journal of the American Geriatrics Society 71, no. 6 (2023): 1931–1936, 10.1111/jgs.18271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Zadik L., Perlman S., Barak O., and Ziv‐Baran T., “Evaluation of Montreal Cognitive Assessment (MoCA) Administered via Videoconference,” Journal of the American Medical Directors Association 24, no. 12 (2023): 1942–1947.e3, 10.1016/j.jamda.2023.08.015. [DOI] [PubMed] [Google Scholar]
- 51. Howland M., Tatsuoka C., Smyth K. A., and Sajatovic M., “Evaluating PROMIS(®) Applied Cognition Items in a Sample of Older Adults at Risk for Cognitive Decline,” Psychiatry Research 247 (2017): 39–42, 10.1016/j.psychres.2016.10.072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Edelen M. O., Harrison J. M., Rodriguez A., et al., “Evaluation of PROMIS Cognitive Function Scores and Correlates in a Clinical Sample of Older Adults,” Gerontology and Geriatric Medicine 8 (2022): 23337214221119057, 10.1177/23337214221119057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Lai J. S., Wagner L. I., Jacobsen P. B., and Cella D., “Self‐Reported Cognitive Concerns and Abilities: Two Sides of One Coin?,” Psycho‐Oncology 23, no. 10 (2014): 1133–1141, 10.1002/pon.3522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Hess C., Levy B., Hashmi A. Z., et al., “Subjective versus Objective Assessment of Cognitive Functioning in Primary Care,” Journal of the American Board of Family Medicine 33, no. 3 (2020): 417–425, 10.3122/jabfm.2020.03.190265. [DOI] [PubMed] [Google Scholar]
- 55. Lau S. C. L., Connor L. T., and Baum C. M., “Subjective and Objective Assessments Are Associated for Physical Function But Not Cognitive Function in Community‐Dwelling Stroke Survivors,” Disability & Rehabilitation 44, no. 26 (2022): 8349–8356, 10.1080/09638288.2021.2012845. [DOI] [PubMed] [Google Scholar]
- 56. Han F., Luo C., Lv D., Tian L., and Qu C., “Risk Factors Affecting Cognitive Impairment of the Elderly Aged 65 and Over: A Cross‐Sectional Study,” Frontiers in Aging Neuroscience 14 (2022): 903794, 10.3389/fnagi.2022.903794. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Phelan E. A., Borson S., Grothaus L., Balch S., and Larson E. B., “Association of Incident Dementia With Hospitalizations,” JAMA 307, no. 2 (2012): 165–172, 10.1001/jama.2011.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Chung S. D., Liu S. P., Sheu J. J., Lin H. C., and Chen C. H., “Increased Healthcare Service Utilizations for Patients With Dementia: A Population‐Based Study,” PLoS One 9, no. 8 (2014): e105789, 10.1371/journal.pone.0105789. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Soley‐Bori M., Ashworth M., Bisquera A., et al., “Impact of Multimorbidity on Healthcare Costs and Utilisation: A Systematic Review of the UK Literature,” British Journal of General Practice 71, no. 702 (2021): e39–e46, 10.3399/bjgp20x713897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Pereira C. P. M., Stella F., Hernandez S. S., Andrade L. P., Texeira C. V., and Gobbi S., “Longitudinal Cognitive Screening Study in Community‐Dwelling Individuals,” Dementia & Neuropsychologia 4, no. 3 (2010): 214–221, 10.1590/s1980-57642010dn40300010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Borson S., Frank L., Bayley P. J., et al., “Improving Dementia Care: The Role of Screening and Detection of Cognitive Impairment,” Alzheimer's & Dementia 9, no. 2 (2013): 151–159, 10.1016/j.jalz.2012.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Shaver J., “The State of Telehealth Before and After the COVID‐19 Pandemic,” Prim Care 49, no. 4 (2022): 517–530, 10.1016/j.pop.2022.04.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Kolluri S., Stead T. S., Mangal R. K., Coffee R. L. Jr., Littell J., and Ganti L., “Telehealth in Response to the Rural Health Disparity,” Health Psychology Research 10, no. 3 (2022): 37445, https://pmc.ncbi.nlm.nih.gov/articles/PMC9392842/. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Barwise A., Huschka T., Woo C., et al., “Perceptions and Use of Telehealth Among Diverse Communities: Multisite Community‐Engaged Mixed Methods Study,” Journal of Medical Internet Research 25 (2023): e44242, 10.2196/44242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Hunter M. B., Jenkins N., Dolan C., Pullen H., Ritchie C., and Muniz‐Terrera G., “Reliability of Telephone and Videoconference Methods of Cognitive Assessment in Older Adults With and Without Dementia,” Journal of Alzheimer’s Disease 81, no. 4 (2021): 1625–1647, 10.3233/jad-210088. [DOI] [PubMed] [Google Scholar]
- 66. Gentry M. T., Lapid M. I., and Rummans T. A., “Geriatric Telepsychiatry: Systematic Review and Policy Considerations,” American Journal of Geriatric Psychiatry 27, no. 2 (2019): 109–127, 10.1016/j.jagp.2018.10.009. [DOI] [PubMed] [Google Scholar]
- 67. Mao A., Tam L., Xu A., et al., “Barriers to Telemedicine Video Visits for Older Adults in Independent Living Facilities: Mixed Methods Cross‐Sectional Needs Assessment,” JMIR Aging 5, no. 2 (2022): e34326, 10.2196/34326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Kruse C., Fohn J., Wilson N., Nunez Patlan E., Zipp S., and Mileski M., “Utilization Barriers and Medical Outcomes Commensurate With the Use of Telehealth Among Older Adults: Systematic Review,” JMIR Medical Informatics 8, no. 8 (2020): e20359, 10.2196/20359. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
